Replies to post #7718 on CytoSorbents Corporation (CTSO)

[dr_lowenstein]

I did it is still a pos stock, thanks though

[snow]

cars

I was a shareholder in this company years ago. My girl friend is still a shareholder. I have thus monitored the lack of significant financial success for years. You assume yourself that revenues will double from year to year from now on. If this happens market cap will still be about 10 times revenues at the beginning of 2018. This is still a very high valuation. There will still be a loss for 2017 I think. I think it is wishful thinking that thousands of lives have so far been saved because of Cytosorbents. There are still no numbers in this respect as far as I know.

[snow]

cars Rapid revenue acceleration?

"The blood purification therapy company posted revenue of $2.1 million in the period, which fell short of Street forecasts." The sluggish growth continues. The pps reflects a disappointed market. There is actually low demand for the filters. They are now avaailable in a lot of countries but that does not seem to boost sales much.